GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuji Pharma Co Ltd (TSE:4554) » Definitions » Other Income (Expense)

Fuji Pharma Co (TSE:4554) Other Income (Expense) : 円749 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuji Pharma Co Other Income (Expense)?

Fuji Pharma Co's other income expense for the Fuji Pharma Co's pretax income for the three months ended in Sep. 2024 was 円-148 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was 円749 Mil.


Fuji Pharma Co Other Income (Expense) Historical Data

The historical data trend for Fuji Pharma Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuji Pharma Co Other Income (Expense) Chart

Fuji Pharma Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -189.00 75.00 19.00 658.00 4,589.00

Fuji Pharma Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,035.00 629.00 73.00 -148.00 195.00

Fuji Pharma Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円749 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuji Pharma Co  (TSE:4554) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Fuji Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.

Fuji Pharma Co Headlines

No Headlines